Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark Corrigan currently holds 28,815 shares of Nabriva Therapeutics plc (NBRV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Corrigan has been a net seller of NBRV stock. They have purchased $0 and sold $11.0M worth of shares.
Mark Corrigan's most recent insider trade was on Dec 8, 2025, when they sold 6,515 shares at $14.07 per share.
Mark Corrigan serves as Executive at Nabriva Therapeutics plc (NBRV). They have executed 139 insider transactions totaling $11.0M over their tenure at the company.
Mark Corrigan holds the position of Executive at Nabriva Therapeutics plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Mark Corrigan has shown a selling trading pattern, with $0 in total purchases and $11.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark Corrigan was on Oct 20, 2009, when they sold $1.6M worth of SEPR shares. This transaction involved 70,668 shares at $23.00 per share.
Mark Corrigan currently owns 28,815 shares of Nabriva Therapeutics plc (NBRV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark Corrigan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark Corrigan has 139 Form 4 filings on record as an insider at Nabriva Therapeutics plc.
Set alerts for Mark Corrigan and 40,000+ other insiders.